---
figid: PMC8820546__pr70_501f2
figtitle: AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin
organisms:
- Homo sapiens
pmcid: PMC8820546
filename: pr70_501f2.jpg
figlink: /pmc/articles/PMC8820546/figure/f2-pr70_501/
number: F2
caption: The role of MTF in metabolism and cancer process through AMPK/mTOR signaling
  pathway. AMPK activation inhibits mTORC1, leading to decreasing of cell growth,
  angiogenesis and Warburg effect, and increasing of apoptosis. ATP adenosine-triphosphate,
  AMP adenosine-monophosphate, ATM ataxia telangiectasia mutated, LKB1 liver kinase
  B1, AMPK adenosine-monophosphate-activated protein kinase, HMG-CoA β-Hydroxy β-methylglutaryl-coenzyme-A,
  IGF-1 insulin-like growth factor 1, IGF-R insulin-like growth factor receptor, PI3K
  phosphatidylinositol-3-kinase, Akt protein kinase B, mTORC1 mammalian target of
  rapamycin complex 1, TSC1,2 tuberous sclerosis complex 1,2, Rheb Ras homolog enriched
  in brain, RAPTOR regulatory-associated protein of mTOR, mTOR mammalian target of
  rapamycin, p53 tumor suppressor protein, p70S6K p70S6 kinase, HIF-1α hypoxia-inducible
  factor 1α, VEGF vascular endothelial growth factor, BAX BCL-2 associated X protein.
papertitle: The Role of AMPK/mTOR Signaling Pathway in Anticancer Activity of Metformin.
reftext: Nikola CHOMANICOVA, et al. Physiol Res. 2021 Aug;70(4):501-508.
year: '2021'
doi: 10.33549/physiolres.934618
journal_title: Physiological Research
journal_nlm_ta: Physiol Res
publisher_name: Institute of Physiology of the Czech Academy of Sciences
keywords: Antidiabetic drug | AMPK activation | Cancer therapy | Apoptosis | Angiogenesis
automl_pathway: 0.8870661
figid_alias: PMC8820546__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8820546__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8820546__pr70_501f2.html
  '@type': Dataset
  description: The role of MTF in metabolism and cancer process through AMPK/mTOR
    signaling pathway. AMPK activation inhibits mTORC1, leading to decreasing of cell
    growth, angiogenesis and Warburg effect, and increasing of apoptosis. ATP adenosine-triphosphate,
    AMP adenosine-monophosphate, ATM ataxia telangiectasia mutated, LKB1 liver kinase
    B1, AMPK adenosine-monophosphate-activated protein kinase, HMG-CoA β-Hydroxy β-methylglutaryl-coenzyme-A,
    IGF-1 insulin-like growth factor 1, IGF-R insulin-like growth factor receptor,
    PI3K phosphatidylinositol-3-kinase, Akt protein kinase B, mTORC1 mammalian target
    of rapamycin complex 1, TSC1,2 tuberous sclerosis complex 1,2, Rheb Ras homolog
    enriched in brain, RAPTOR regulatory-associated protein of mTOR, mTOR mammalian
    target of rapamycin, p53 tumor suppressor protein, p70S6K p70S6 kinase, HIF-1α
    hypoxia-inducible factor 1α, VEGF vascular endothelial growth factor, BAX BCL-2
    associated X protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - RPTOR
  - CCND1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ATM
  - STK11
  - TP53
  - TP63
  - TP73
  - BAX
  - HIF1A
  - RHEB
  - RHEBP1
  - RPS6KB1
  - RPS6KB2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - TSC1
  - CCL26
  - TSC2
  - IGF1
  - AKT1
  - AKT2
  - AKT3
  - IGF1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
---
